%A Srivastava,Gitanjali %A Apovian,Caroline M. %D 2019 %J Frontiers in Endocrinology %C %F %G English %K Anti-obesity medications,Bariatric / metabolic surgery,lifestyle intervention,Pharmacotherapy,severe obesity %Q %R 10.3389/fendo.2019.00635 %W %L %M %P %7 %8 2019-October-02 %9 Case Report %# %! Patient with Severe Obesity %* %< %T Clinical Challenge: Patient With Severe Obesity BMI 46 kg/m2 %U https://www.frontiersin.org/articles/10.3389/fendo.2019.00635 %V 10 %0 JOURNAL ARTICLE %@ 1664-2392 %X Obesity causes and exacerbates many disease processes and affects every organ system. Thus it is not surprising that clinical providers are often overwhelmed with the multitude of symptomatology upon initial presentation in patients with obesity. However, despite a “complicated medical history,” a systematic, organized approach in obesity medicine utilizes a personalized-tailored treatment strategy coupled with understanding of the disease state, presence of comorbidities, contraindications, side effects, and patient preferences. Here, we present the case of a young patient with Class 3b severe obesity, several obesity-related complications, and extensive psychological history. Through synergistic and additive treatments (behavioral/nutritional therapy combined with anti-obesity pharmacotherapy and concurrent enrollment in our bariatric surgery program), the patient was able to achieve significant −30.5% total body weight loss with improvement of metabolic parameters. Though these results are not typical of all patients, we must emphasize the need to encompass all available anti-obesity therapies (lifestyle, pharmacotherapy, medical devices, bariatric surgery in monotherapy or combination) in cases of refractory or severe obesity, as we do similarly for other disease modalities such as refractory hypertension or poorly controlled Type 2 diabetes that requires robust escalation in therapy.